These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 743928)

  • 21. [Effect of antineoplastic drug therapy in the management of tumor cells of pleural and ascitic effusion].
    Manzur R; Oliva Otero G; Tano Assini MT
    Prensa Med Argent; 1970 Apr; 57(6):299-301. PubMed ID: 5452866
    [No Abstract]   [Full Text] [Related]  

  • 22. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: a randomized study.
    Kefford RF; Woods RL; Fox RM; Tatterall MH
    Med J Aust; 1980 Oct; 2(8):447-8. PubMed ID: 7010099
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intrapleural tetracycline in the treatment of malignant pleural effusions].
    Jensen JJ; Daugaard JJ
    Tidsskr Nor Laegeforen; 1988 Jun; 108(17-18):1403-4. PubMed ID: 3388371
    [No Abstract]   [Full Text] [Related]  

  • 24. Pleural effusion in lung cancer.
    Sahn SA
    Clin Chest Med; 1982 May; 3(2):443-52. PubMed ID: 7047062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of malignant pleural effusions.
    Anderson CB; Philpott GW; Ferguson TB
    Cancer; 1974 Apr; 33(4):916-22. PubMed ID: 4362107
    [No Abstract]   [Full Text] [Related]  

  • 26. [The use of nitrogen mustards by intrapleural route in the treatment of metastatic pleural effusions].
    ENNUYER A; HELARY J
    J Fr Med Chir Thorac; 1961; 15():673-9. PubMed ID: 13890333
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intrapleural administration of CDDP against malignant pleural effusions in breast cancer].
    Kikuchi K; Tsuyuki A; Fujishiro Y; Utsumi T; Fujisaki M; Kurihara E; Uematsu M
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1905-8. PubMed ID: 2393307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
    Matsuda M; Morishita T; Horai T; Ikegami H; Nakamura S; Nishio H
    Gan No Rinsho; 1983 Aug; 29(9):955-61. PubMed ID: 6620573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
    Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Attack treatment of broncho-pleuro-pulmonary cancer by polychemotherapy under the protection of phytohemagglutinin].
    Brocard H; Akoun G; Turpin G; Gendre JP
    Bull Mem Soc Med Hop Paris; 1967 Jan; 118(2):139-56. PubMed ID: 6061578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrapleural streptokinase in multiloculated malignant pleural effusion.
    Dixit R; Dixit K; Bansal R
    Indian J Chest Dis Allied Sci; 2004; 46(1):59-62. PubMed ID: 14870872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrapleural streptokinase in management of parapneumonic effusions. Report of series and review of literature.
    Mitchell ME; Alberts WM; Chandler KW; Goldman AL
    J Fla Med Assoc; 1989 Dec; 76(12):1019-22. PubMed ID: 2689573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
    Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
    Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of malignant pleural effusion with doxycycline.
    Månsson T
    Scand J Infect Dis Suppl; 1988; 53():29-34. PubMed ID: 3166542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oxytetracycline, vehicle for therapeutic drugs, fluorouracil and nitrogen mustard, in the treatment of gastrointestinal tumors].
    Gordon B
    Hospital (Rio J); 1970 Apr; 77(4):1243-68. PubMed ID: 4939509
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.
    Montaldo PG; Figoli F; Zanette ML; Sorio R; Zucchetti M; Tirelli U; D'Incalci M
    Oncology; 1990; 47(1):55-61. PubMed ID: 2300386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of intrapleural urokinase in children].
    Tapia Ceballos L; Picazo Angelín B; Bonillo Perales A; Romero Sánchez J; Díaz Cabrera R; Romero González J
    An Esp Pediatr; 2000 Mar; 52(3):281-4. PubMed ID: 11003910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aclacinomycin; benefits for the treatment of malignant pleural effusion].
    Homma T; Min KY; Yoneda S; Yoshida S; Nakagawa H
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1810-6. PubMed ID: 6309098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.